The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
mBio · 2023
DOI: 10.1128/mbio.00353-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Sivaranjani Namasivayam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethes…. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Previous studies have shown that treatment of Mycobacterium tuberculosis infection with first-line antibiotics results in a long-lasting disruption of the host microbiota. Since the microbiome has been shown to influence the host availability of other drugs, we employed a mouse model to ask whether the dysbiosis resulting from either tuberculosis (TB) chemotherapy or a more aggressive course of broad-spectrum antibiotics might influence the pharmacokinetics of the TB antibiotics themselves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
- Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, New Jersey, USA.
ORCID-Profile: Véronique Dartois
Förderung
- NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Namasivayam, S., Zimmerman, M., Oland, S., Wang, H., Mittereder, L. R., Dartois, V., & Sher, A. (2023). The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. mBio. https://doi.org/10.1128/mbio.00353-23
Vancouver
Namasivayam S, Zimmerman M, Oland S, Wang H, Mittereder LR, Dartois V, et al. The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. mBio. 2023. doi:10.1128/mbio.00353-23
BibTeX
@article{Namasivayam2023,
author = {Namasivayam, Sivaranjani and Zimmerman, Matthew and Oland, Sandra and Wang, Han and Mittereder, Lara R and Dartois, Véronique and Sher, Alan},
title = {The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.00353-23}
}
EUVIMED